| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |